Pepijn van Houten

8PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Cellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 08, 2026
Clinical actionability of molecular testing in advanced thyroid cancer: a real-world cohort study.

|Apr 03, 2026
Delivering cytokine mRNA to secondary lymphoid organs for robust cancer immunotherapy.

Willem Mulder, Tom Anbergen, Yuri van Elsas

|Dec 19, 2025
Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer.

Prashant Changoer, Chunying Peng, Pepijn van Houten

|Dec 11, 2025
High Local and Systemic Expression of Pentraxin-3 in Anaplastic Thyroid Cancer.

Andreea Bojoga, Pepijn van Houten, Martin Jaeger

|Mar 24, 2025
High recovery rate of adrenal function after successful surgical treatment of Cushing's syndrome.

Annenienke C van de Ven, Pepijn van Houten, Lisan Grevers

|Jul 24, 2024
Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma.

Pepijn van Houten, James Nagarajah, Janneke E W Walraven

Pageof 2

Frequent Collaborators

2 joint publications

Martin Jaeger

2 joint publications

Romana T Netea-Maier

2 joint publications

Prashant Changoer

1 joint publications

Chunying Peng